Navigation Links
Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine,in Glioma Presented at American Association of Neurological,Surgeons Annual Meeting

ough our survival data are encouraging, a larger Phase 2 study will be required to determine the benefit of Oncophage for patients with recurrent glioma. The consistent, tumor-specific immune response seen in these patients suggests that in the right patient population, Oncophage could have a significant impact."

About Brain and Spinal Cord Tumors

Glioma is a cancer affecting the central nervous system that begins in glial cells (connective tissue cells that surround and support nerve cells). Malignant glioma is currently a fatal disease. The American Cancer Society estimates that 20,500 malignant tumors of the brain or spinal cord will be diagnosed during 2007 in the United States, and that about 12,740 people will die from these tumors. Brain and spinal cord tumors account for about 1 percent of all cancers and 2 percent of all cancer-related deaths.

About UCSF

UCSF is a leading university that consistently defines health care worldwide by conducting advanced biomedical research, educating graduate students in the life sciences, and providing complex patient care. For more information, please visit www.ucsf.edu.

About Antigenics

Antigenics (NASDAQ: AGEN) is a biotechnology company working to develop treatments for cancers and infectious diseases. The company's investigational product portfolio includes Oncophage(R) (vitespen), a patient-specific therapeutic cancer vaccine being evaluated in several indications; Aroplatin(TM) (L-NDDP), a liposomal, third-generation platinum chemotherapeutic; AG-707, a therapeutic vaccine for the treatment of genital herpes; and QS-21, an adjuvant being evaluated by Antigenics' corporate partners in several late-stage clinical trials. For more information, please visit www.antigenics.com.

This press release contains forward-looking information, including statements regarding the potential safety and activity of Oncophage in patients with glioma, publication plans and future clinical t
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
3. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
4. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
5. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
6. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
7. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
8. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
9. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
Post Your Comments:
(Date:5/4/2015)... Md. , May 4, 2015   Synthetic ... pathogen-specific therapeutics focused on protecting the microbiome, as well ... has been appointed Chief Financial Officer, Treasurer and ... Evan Ballantyne who will be leaving the Company ... Shallcross brings to Synthetic Biologics operational, financial and international ...
(Date:5/4/2015)... and COLUMBIA, Maryland , May ... SHP, NASDAQ: SHPG ) and the Foundation Fighting ... research for a novel treatment for autosomal dominant retinitis ... occurs in late childhood or adolescence and is followed ... no currently approved treatment options for adRP. ...
(Date:5/4/2015)... , le 4 mai 2015  Lors du ... /Allemagne (hall 5, stand 5510), North Star Imaging ... système à rayons X spécialement conçu pour la ... sur les rayons X, la CXMM 50, a ... système de métrologie destiné à offrir à l,utilisateur ...
Breaking Medicine Technology:Steven Shallcross Named Chief Financial Officer of Synthetic Biologics 2Steven Shallcross Named Chief Financial Officer of Synthetic Biologics 3Shire and Foundation Fighting Blindness Announce New Research Agreement 2Shire and Foundation Fighting Blindness Announce New Research Agreement 3NSI sera présente lors du salon Control 2015, du 5 au 8 mai à Stuttgart, en Allemagne : axer la GMAO vers une nouvelle dimension 2
... Quest Diagnostics Incorporated (NYSE: DGX ), the ... announced the availability in Europe of the Simplexa C. ... The new CE marked in vitro diagnostic (IVD) ... traditional extraction step and allowing for processing of up to ...
... 2011 Bacterin International Holdings, Inc. ("Bacterin") ... developer of revolutionary bone graft material and antimicrobial coatings ... distribution of the Company,s third human acellular biological scaffold, ... hMatrix® is an acellular matrix processed from donated human ...
Cached Medicine Technology:Quest Diagnostics Launches Simplexa™ C. Difficile Universal Direct Test in Europe 2Quest Diagnostics Launches Simplexa™ C. Difficile Universal Direct Test in Europe 3Quest Diagnostics Launches Simplexa™ C. Difficile Universal Direct Test in Europe 4Bacterin International Holdings Launches Third Biologic Scaffold 2Bacterin International Holdings Launches Third Biologic Scaffold 3
(Date:5/4/2015)... 04, 2015 World T.E.A.M. Sports’ best-attended ... ride in the last decade arrived in this historic ... in two days from the Pentagon in Arlington, Virginia. ... registered disabled and able-bodied participants work together to successfully ... and honors the commitment and sacrifices by military veterans ...
(Date:5/4/2015)... 04, 2015 “ Food Cost Calculator ” ... which takes a look at the latest and coolest applications ... the host of AppWatch and technology expert, conducted the app ... owners to manage and efficiently calculate food costs. , The ... In fact, the industry has an estimated 1.8 trillion dollar ...
(Date:5/4/2015)... 04, 2015 Peacock Alley knows ... He said, “My mother was the most beautiful woman I ... in lovely, feminine prints and textures to remind ... further than the Eloise Robe to get you there. The ... cap sleeve and tapered waist. It is available in small/medium ...
(Date:5/4/2015)... Sara Soulati, CEO of Global Cardio ... Los Angeles associated with the field of Enhanced External ... Sara Soulati Health For Life Program (SSHFLP). , The ... modification and disease prevention program. A provisional patent ... Patents and Trademarks Office and is now under review ...
(Date:5/3/2015)... May 03, 2015 Women’s Excellence ... Facebook page. , Their Facebook page consists ... services the Practice has, it’s multiple locations, Providers and ... Excellence has a very strong social media presence, with ... You Tube. , Women’s Excellence is the most ...
Breaking Medicine News(10 mins):Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 2Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 3Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 4Health News:An Application to Manage a Successful Restaurant Was Featured on NewsWatch Television 2Health News:Feminine Classics for Mother's Day Gifts from Peacock Alley 2Health News:CEO Sara Soulati Announces Patent-Pending Designation For The Sara Soulati Health For Life Program 2
... TV/Channel 7 and The,Detroit Department of Health and Wellness ... "boost" at the 31st annual "HEALTHY LIVING,FOR KIDS" program. ... 24,2008 from 10 a.m. to 5 p.m. at the ... inception in 1977, "Healthy Living for Kids",has provided free ...
... -- Tianyin,Pharmaceutical, Co., Inc. (OTC Bulletin Board: TYNP, ... medicine ("TCM") based in,Chengdu, China, today announced that ... OTC BB: TYNPE due to the electronic eligibility,system ... and the Company expects the,stock symbol to trade ...
... Fourteen physicians who have been,part of Commonwealth Medical ... and service they provide to their patients by joining ... and we are delighted they,have decided to join our ... officer. "We look forward to working with,them to support ...
... Aug. 20 Governor Edward,G. Rendell today said ... and a broken healthcare system, underscoring the need,to ... more,affordable for working adults., Nearly 900 guests ... & Industry Day Luncheon at Ag Progress Days, ...
... traitors, good cells gone bad. They evade the body,s defense ... , But researchers at the University of North Carolina at ... way to blow their cover. , Moo J. Cho, Ph.D., ... system that would embed bacterial elements in a cancer tumor ...
... found that infusions of a particular bone marrow stem ... in a mouse model. In their report published ... from the MGH Center for Engineering in Medicine report ... immune system activities, allowed the regeneration of the gastrointestinal ...
Cached Medicine News:Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3Health News:Tianyin Pharmaceutical Co., Inc. Announces Trading Symbol Error and Correction 2Health News:Commonwealth Medical Group Physicians to Join Aurora Health Care 2Health News:Pennsylvania Governor Rendell Highlights Renewable Energy, Health Care Reform at Ag Progress Days 2Health News:UNC researcher aims to 'unmask' cancer cells to trigger body's immune system 2Health News:Bone marrow stem cells may help control inflammatory bowel disease 2Health News:Bone marrow stem cells may help control inflammatory bowel disease 3
... bed side and near patient testing is ... growth has posed unique problems for hospitals ... quality responsibility to decentralized areas focused on ... the problem is the reality of controlling ...
... The GenoSensor System includes genomic ... software, and reagents. By utilizing ... (CGH) technology for multi-target assessment, ... analyze multiple genomic targets in ...
... The CELL-DYN 3700 combines optical light ... Polarized Scatter Separation (MAPSS) to fully ... to improve performance and productivity in ... the revolutionary concept of complementary technologies ...
... Data Networking is hospital bedside glucose ... networking. In seconds, point of care ... from nursing stations throughout the hospital ... available to laboratory staff and the ...
Medicine Products: